{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ01195",
      "entity_text" : "BSA5",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:O94972",
      "entity_text" : "muL",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "In short, 30 muL citrated WB was mixed with 10 muL rhodamine substrate (thrombin specific fluorogenic substrate, 1.8 mM) and activated with 20 muL of either a mix of CaCl 2 (50 mM) and HEPES buffer containing 5 mg/mL BSA (BSA5) with / without TF, or a calibrator (alpha 2 -macroglobulin - thrombin complex, in-house prepared, 300 nM thrombin activity).",
  "reading_complete" : "2020-08-02T11:30:49Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T11:28:25Z",
  "trigger" : "activated",
  "evidence" : [ "muL citrated WB was mixed with 10 muL rhodamine substrate (thrombin specific fluorogenic substrate, 1.8 mM) and activated with 20 muL of either a mix of CaCl\n 2 \n(50 mM) and HEPES buffer containing 5 mg/mL BSA (BSA5" ],
  "pmc_id" : "6645913",
  "score" : 0
}